CN110604775A - 一种用于治疗肿瘤的中药组合物及制备方法 - Google Patents
一种用于治疗肿瘤的中药组合物及制备方法 Download PDFInfo
- Publication number
- CN110604775A CN110604775A CN201910993772.2A CN201910993772A CN110604775A CN 110604775 A CN110604775 A CN 110604775A CN 201910993772 A CN201910993772 A CN 201910993772A CN 110604775 A CN110604775 A CN 110604775A
- Authority
- CN
- China
- Prior art keywords
- parts
- traditional chinese
- chinese medicine
- medicine composition
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 49
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 37
- 238000002360 preparation method Methods 0.000 title claims description 20
- 239000003814 drug Substances 0.000 claims abstract description 83
- 241000222336 Ganoderma Species 0.000 claims abstract description 15
- 235000002789 Panax ginseng Nutrition 0.000 claims abstract description 10
- 241000282817 Bovidae Species 0.000 claims abstract description 9
- 241000254173 Coleoptera Species 0.000 claims abstract description 9
- 241000402754 Erythranthe moschata Species 0.000 claims abstract description 9
- 241000218206 Ranunculus Species 0.000 claims abstract description 9
- 210000003608 fece Anatomy 0.000 claims abstract description 9
- 241000045403 Astragalus propinquus Species 0.000 claims abstract description 8
- 241001022083 Flemingia Species 0.000 claims abstract description 8
- 235000006533 astragalus Nutrition 0.000 claims abstract description 8
- 241000722809 Armadillidium vulgare Species 0.000 claims abstract description 7
- 240000006688 Telosma cordata Species 0.000 claims abstract description 6
- 235000017352 Telosma cordata Nutrition 0.000 claims abstract description 6
- 241000257303 Hymenoptera Species 0.000 claims abstract description 5
- 239000000344 soap Substances 0.000 claims abstract description 3
- 239000002994 raw material Substances 0.000 claims description 27
- 239000000843 powder Substances 0.000 claims description 17
- 229940079593 drug Drugs 0.000 claims description 13
- 239000007788 liquid Substances 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 235000011837 pasties Nutrition 0.000 claims description 9
- 239000003937 drug carrier Substances 0.000 claims description 7
- 241000931143 Gleditsia sinensis Species 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 241000208340 Araliaceae Species 0.000 claims description 5
- 241000722823 Armadillidium Species 0.000 claims description 5
- 241001251068 Formica fusca Species 0.000 claims description 5
- 244000153234 Hibiscus abelmoschus Species 0.000 claims description 5
- 239000009636 Huang Qi Substances 0.000 claims description 5
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 5
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 5
- 239000002775 capsule Substances 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 235000008434 ginseng Nutrition 0.000 claims description 5
- 239000008187 granular material Substances 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 238000012545 processing Methods 0.000 claims description 5
- 239000003826 tablet Substances 0.000 claims description 5
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims description 4
- 201000005202 lung cancer Diseases 0.000 claims description 4
- 208000020816 lung neoplasm Diseases 0.000 claims description 4
- 208000000461 Esophageal Neoplasms Diseases 0.000 claims description 3
- 208000005718 Stomach Neoplasms Diseases 0.000 claims description 3
- 201000004101 esophageal cancer Diseases 0.000 claims description 3
- 239000000284 extract Substances 0.000 claims description 3
- 206010017758 gastric cancer Diseases 0.000 claims description 3
- 201000011549 stomach cancer Diseases 0.000 claims description 3
- 241001253169 Asystasia gangetica Species 0.000 claims description 2
- 206010006187 Breast cancer Diseases 0.000 claims description 2
- 208000026310 Breast neoplasm Diseases 0.000 claims description 2
- 208000005016 Intestinal Neoplasms Diseases 0.000 claims description 2
- 239000004480 active ingredient Substances 0.000 claims description 2
- 201000002313 intestinal cancer Diseases 0.000 claims description 2
- 201000007270 liver cancer Diseases 0.000 claims description 2
- 208000014018 liver neoplasm Diseases 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims description 2
- 206010030155 Oesophageal carcinoma Diseases 0.000 claims 1
- 238000005259 measurement Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 description 25
- 231100000331 toxic Toxicity 0.000 description 9
- 230000002588 toxic effect Effects 0.000 description 9
- 230000001737 promoting effect Effects 0.000 description 8
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 230000008961 swelling Effects 0.000 description 7
- 208000002193 Pain Diseases 0.000 description 6
- 201000011510 cancer Diseases 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- 230000036407 pain Effects 0.000 description 6
- 238000001959 radiotherapy Methods 0.000 description 6
- 238000012360 testing method Methods 0.000 description 5
- 210000004881 tumor cell Anatomy 0.000 description 5
- 206010007247 Carbuncle Diseases 0.000 description 4
- 206010017553 Furuncle Diseases 0.000 description 4
- 206010027476 Metastases Diseases 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 238000002512 chemotherapy Methods 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 201000007227 lymph node tuberculosis Diseases 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000009401 metastasis Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 206010010904 Convulsion Diseases 0.000 description 3
- 201000007100 Pharyngitis Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 208000004078 Snake Bites Diseases 0.000 description 3
- 206010042674 Swelling Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 230000036461 convulsion Effects 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 206010015037 epilepsy Diseases 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 235000019640 taste Nutrition 0.000 description 3
- 231100000167 toxic agent Toxicity 0.000 description 3
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000010228 Erectile Dysfunction Diseases 0.000 description 2
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 210000001185 bone marrow Anatomy 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000011132 hemopoiesis Effects 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 210000004088 microvessel Anatomy 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000011127 radiochemotherapy Methods 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 235000019643 salty taste Nutrition 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 201000008827 tuberculosis Diseases 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 206010001580 Albuminuria Diseases 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 description 1
- 206010007134 Candida infections Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 208000010833 Chronic myeloid leukaemia Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010012689 Diabetic retinopathy Diseases 0.000 description 1
- 206010055690 Foetal death Diseases 0.000 description 1
- 240000008397 Ganoderma lucidum Species 0.000 description 1
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 241000167847 Koelreuteria paniculata Species 0.000 description 1
- 208000019395 Lactation disease Diseases 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 1
- 206010061876 Obstruction Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000007027 Oral Candidiasis Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 206010039710 Scleroderma Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 206010067868 Skin mass Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010042576 Suppressed lactation Diseases 0.000 description 1
- 208000024770 Thyroid neoplasm Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 241000287411 Turdidae Species 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 208000002495 Uterine Neoplasms Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 229940107666 astragalus root Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 201000003984 candidiasis Diseases 0.000 description 1
- 206010007625 cardiogenic shock Diseases 0.000 description 1
- 230000007681 cardiovascular toxicity Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000002920 convulsive effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000000120 cytopathologic effect Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 201000001981 dermatomyositis Diseases 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 208000010515 dystocia Diseases 0.000 description 1
- 208000002296 eclampsia Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 235000021059 hard food Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000004957 immunoregulator effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 208000025036 lymphosarcoma Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 208000011581 secondary neoplasm Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 208000013076 thyroid tumor Diseases 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 206010046766 uterine cancer Diseases 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/55—Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/483—Gleditsia (locust)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/86—Violaceae (Violet family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Insects & Arthropods (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Developmental Biology & Embryology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- Rheumatology (AREA)
- Animal Husbandry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Oncology (AREA)
- Endocrinology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公布了一种用于治疗肿瘤的中药组合物,该中药组份以及各组份的重量份数为黄芪10~20份,红参5~10份,灵芝5~10份,千斤拔5~10份,羚羊角0.1~0.3份,蚂蚁3~9份,皂针5~10份,猫爪草10~15份,紫花地丁10~15份,蜣螂5~10份,鼠妇3~9份,麝香0.1~0.3份。本发明中药组合物经过科学配伍,可有效对抗化放疗损伤,修复人体正常机能,杜绝肿瘤细胞再生之源,辅助抑制肿瘤细胞的复发和转移;同时,促使微血管扩张,加速血液循环,促进骨髓造血,提高免疫力达到较好的肿瘤治疗效果。
Description
技术领域
本发明涉及中药技术领域,具体涉及一种用于治疗肿瘤的中药组合物及制备方法。
背景技术
随着人们生活压力的增大以及生态环境的恶化,肿瘤的发病率和死亡率逐年上升,严重威胁人们的健康,已成为人类死亡的主要原因之一,目前治疗恶性肿瘤多采用西医手段如手术切除、放射治疗和化学药物治疗,我国80%的肿瘤患者在有意或被迫接受着超过疾病需要的过度治疗,他(她)们忍受着常人不能忍受的痛苦,常规使用的放化疗方案在杀伤肿瘤细胞的同时,也大量的杀伤正常组织细胞,对人体有着较大毒副作用,会给患者带来诸多的不良反应,主要表现有血液毒性、消化道毒性、粘膜损伤以及原发性二次肿瘤等;同时,在放化疗过程中对患者身体产生巨大的痛苦,吞噬着患者的生存意志,导致患者痛苦地走完人生历程。在治疗恶性肿瘤的过程中,除了采用西医手段,中药对肿瘤患者的辅助治疗作用也越来越得到认可。中医认为肿瘤是气血流而不通瘀阻而成,当人体内正气不足不能推动血畅流时就会留在那里成瘀滞物,年长日久不能疏通导致发生恶变,从而变成癌。相对于西医治疗方法来说,中药在治疗肿瘤方面,相对化疗和放疗副反应较少,且能对抗肿瘤化疗和放疗造成的损伤,提高肿瘤患者的免疫指标,采用中西医结合的方法形成西医攻邪、中医扶正的格局,对治疗恶性肿瘤往往能取得较好的效果。
发明内容
针对上述问题,本发明提供一种用于治疗肿瘤的中药组合物及制备方法,该中药组合物经过科学配伍,使用该中药组合物有效对抗化放疗损伤,修复人体正常机能,杜绝肿瘤细胞再生之源,辅助抑制肿瘤细胞的复发和转移;同时,促使微血管扩张,加速血液循环,促进骨髓造血,提高免疫力,达到较好的肿瘤治疗效果。为此,本发明提供如下技术方案:
一种用于治疗肿瘤的中药组合物,该中药组份以及各组份的重量份数为黄芪10~20份,红参5~10份,灵芝5~10份,千斤拔5~10份,羚羊角0.1~0.3份,蚂蚁3~9份,皂针5~10份,猫爪草10~15份,紫花地丁10~15份,蜣螂5~10份,鼠妇3~9份,麝香0.1~0.3份。
上述的,该中药组份以及各组份的重量份数为黄芪15份,红参8份,灵芝8份,千斤拔8份,羚羊角0.2份,蚂蚁6份,皂针7份,猫爪草13份,紫花地丁13份,蜣螂7份,鼠妇6份,麝香0.2份。
上述的,该中药组合物重量单位为克或千克为计量单位,依据所需数量而定。
上述的,所述的中药组合物以原料的溶剂提取物为活性成分,加上药学上可接收的载体制成的制剂。
上述的,所述的制剂为口服液、颗粒剂、胶囊剂或片剂。
本发明提供一种用于治疗肿瘤的中药组合物的制备方法,该方法包括以下步骤:
步骤1:取得黄芪、红参、灵芝、千斤拔、羚羊角、蚂蚁、皂针、猫爪草、紫花地丁、蜣螂、鼠妇、麝香原材料,分别进行炮制,制得原料药,备用;
步骤2:将步骤1制得原料药分别进行粉碎至80~120目,采用超声波设备对原料药粉末进行破壁,得到原料药的破壁粉末备用;
步骤3:将上述的破壁粉末加入原料药总重量4-8倍量水加热循环煎煮2~5次,每次煎煮时长为1~3h,过滤后将煎煮药液在恒温50-55℃条件下浓缩至含水量在50%~60%的膏状药剂,即为所述得中药组合物。
步骤4:将步骤3中所述的膏状药剂加入药物学可接受的载体制备制剂。
上述的,所述的中药组合物可用于治疗肺癌、肝癌、胃癌、食道癌、乳腺癌、肠癌、子宫癌中的任意一种。
本发明中药组合物各中药成分的药理功效为:
黄芪:味甘,性微温;归脾、肺经。具有补气固表、托毒排脓、利尿、生肌之功效。主治气虚乏力、久泻脱肛、自汗、水肿、子宫脱垂、慢性肾炎蛋白尿、糖尿病、疮口久不愈合。
红参:味甘、微苦,性温、平。具有大补元气、复脉固脱、补脾益肺、生津、安神之功效。主治用于体虚欲脱、肢冷脉微、脾虚食少、肺虚喘咳、津伤口渴、内热消渴、久病虚羸、惊悸失眠、阳痿宫冷、心力衰竭、心原性休克。现代药理学研究表明红参具有抗糖尿病作用,对糖尿病视网膜病变具有保护作用,还具有抗氧化、抗肿瘤、抗衰老等作用。
灵芝:性温,味微苦涩。具有滋补强壮之功能。主治健脑、消炎、利尿、益肾。灵芝所含的最有效成分之一灵芝多糖具有抗肿瘤及免疫调节功效。
千斤拔:味辛,性温。具有祛风利湿、消瘀解毒之功效。主治治风湿痹痛、慢性肾炎、跌打损伤、痈肿、喉蛾。
羚羊角:味咸,性寒。具有平肝息风、清肝明目、散血解毒之功效。主治肝风内动、惊痫抽搐、妊娠子痫、高热痉厥、癫痫发狂、头痛眩晕、目赤翳障、温毒发斑、痈肿疮毒。
蚂蚁:味咸、酸,性平。具有补肾益精、通经活络、解毒消肿之功效。主治肾虚头昏耳鸣、失眠多梦、阳痿遗精、风湿痹痛、中风偏瘫、手足麻木、红斑性狼疮、硬皮病、皮肌炎、痈肿疔疮、毒蛇咬伤。
皂针:味辛,性温。具有消毒透脓、搜风、杀虫、抗癌之功效。主治痈疽肿毒、瘰疬、疮疹顽癣、产后缺乳、胎衣不下。
猫爪草:甘辛,温,性平。具有解毒、化痰散结的功效,主治瘰疬、结核、咽炎、疔疮、蛇咬伤、疟疾、偏头痛、牙痛。科学研究表明猫爪草提取物皂苷及多糖在治疗颈淋巴结结核,抗癌应用方面(包括甲状腺肿瘤、淋巴肉瘤、慢性粒细胞白血病、肺癌等)具有显著的临床疗效。
紫花地丁:味苦、辛,性寒。具有清热解毒、凉血消肿、清热利湿之功效。主治疔疮、痈肿、瘰疬、黄疸、痢疾、腹泻、目赤、喉痹、毒蛇咬伤。
蜣螂:味咸,性寒。具有破瘀、定惊、通便、散结、拔毒去腐之功效。主治癓瘕、惊痫、噎膈反胃、腹胀便秘、痔漏、疔肿、恶疮。
鼠妇:味酸,性凉。具有破血、利水、解毒、止痛之功效。主治治久疟疟母、经闭症瘕、小便不通、惊风撮口、口齿疼痛、鹅口诸疮。
麝香:味辛,性温。具有开窍醒神、活血通经、消肿止痛之功效。主治闭证神昏、疮疡肿毒、瘰疬痰核、咽喉肿痛、血瘀经闭、症瘕、心腹暴痛、头痛、跌打损伤、风寒湿痹、难产、死胎、胞衣不下。
本发明的有益效果:本发明的中药组合物,配方合理,疗效独特,该中药组合物经过科学配伍,具有抗癌解毒的功效,使用该中药组合物有效对抗化放疗损伤,修复人体正常机能,杜绝肿瘤细胞再生之源,辅助抑制肿瘤细胞的复发和转移;同时,促使微血管扩张,加速血液循环,促进骨髓造血,提高免疫力,达到较好的肿瘤预防效果;该中药组合物安全性高、毒副作用低,能够很好的改善患者病症,减少肿瘤患者的痛苦,延长患者的生存期限,提高患者的治疗质量。
具体实施方式
为了使本技术领域的人员更好地理解本发明的方案,以下是对本发明实施例作进一步的详细说明。
实施例1
一种用于治疗肿瘤的中药组合物,该中药组份以及各组份的重量份数为黄芪10份,红参5份,灵芝5份,千斤拔5份,羚羊角0.1份,蚂蚁3份,皂针5份,猫爪草10份,紫花地丁10份,蜣螂5份,鼠妇3份,麝香0.1份。
所述的中药组合物的制备方法,该方法包括以下步骤:
步骤1:取得黄芪、红参、灵芝、千斤拔、羚羊角、蚂蚁、皂针、猫爪草、紫花地丁、蜣螂、鼠妇、麝香原材料,分别进行炮制,制得原料药,备用;
步骤2:将步骤1制得原料药分别进行粉碎至80~120目,采用超声波设备对原料药粉末进行破壁,得到原料药的破壁粉末备用;
步骤3:将上述的破壁粉末加入原料药总重量4倍量水加热循环煎煮2次,每次煎煮时长为1 h,过滤后将煎煮药液在恒温55℃条件下浓缩至含水量在50%~60%的膏状药剂,即为所述得中药组合物。
步骤4:将步骤3中所述的膏状药剂加入药物学可接受的载体制备制剂,制备成口服液、颗粒剂、胶囊剂或片剂。
实施例2
一种用于治疗肿瘤的中药组合物,该中药组份以及各组份的重量份数为黄芪20份,红参0份,灵芝10份,千斤拔10份,羚羊角0.3份,蚂蚁9份,皂针10份,猫爪草15份,紫花地丁15份,蜣螂10份,鼠妇9份,麝香0.3份。
所述中药组合物的制备方法,该方法包括以下步骤:
步骤1:取得黄芪、红参、灵芝、千斤拔、羚羊角、蚂蚁、皂针、猫爪草、紫花地丁、蜣螂、鼠妇、麝香原材料,分别进行炮制,制得原料药,备用;
步骤2:将步骤1制得原料药分别进行粉碎至80~120目,采用超声波设备对原料药粉末进行破壁,得到原料药的破壁粉末备用;
步骤3:将上述的破壁粉末加入原料药总重量8倍量水加热循环煎煮5次,每次煎煮时长为3h,过滤后将煎煮药液在恒温55℃条件下浓缩至含水量在50%~60%的膏状药剂,即为所述得中药组合物。
步骤4:将步骤3中所述的膏状药剂加入药物学可接受的载体制备制剂,制备成口服液、颗粒剂、胶囊剂或片剂。
实施例3
一种用于治疗肿瘤的中药组合物,该中药组份以及各组份的重量份数为黄芪15份,红参8份,灵芝8份,千斤拔8份,羚羊角0.2份,蚂蚁6份,皂针7份,猫爪草13份,紫花地丁13份,蜣螂7份,鼠妇6份,麝香0.2份。
所述的中药组合物的制备方法,该方法包括以下步骤:
步骤1:取得黄芪、红参、灵芝、千斤拔、羚羊角、蚂蚁、皂针、猫爪草、紫花地丁、蜣螂、鼠妇、麝香原材料,分别进行炮制,制得原料药,备用;
步骤2:将步骤1制得原料药分别进行粉碎至80~120目,采用超声波设备对原料药粉末进行破壁,得到原料药的破壁粉末备用;
步骤3:将上述的破壁粉末加入原料药总重量6倍量水加热循环煎煮4次,每次煎煮时长为3h,过滤后将煎煮药液在恒温55℃条件下浓缩至含水量在50%~60%的膏状药剂,即为所述得中药组合物。
步骤4:将步骤3中所述的膏状药剂加入药物学可接受的载体制备制剂,制备成口服液、颗粒剂、胶囊剂或片剂。
一、该中药组合物的临床试验:
采用配方比例制备的中药组合物,进行肿瘤治疗临床试验,各选取150名病患分别采用中药组合物散剂的试验组和采用放化疗治疗的对照组,试验组按医嘱每日早中晚三次服用,每次3~5g,实验进行5个疗程,每个疗程15天,统计患者病患情况,统计结果如表1所示:
表1 中药组合物临床实验效果数据
注:1)治愈:患者经过治疗后,肿瘤瘤体缩小10%以上,临床症状消失,且连续观察一年无复发者;2)显效:患者经过治疗后,肿瘤瘤体缩小1%~10%,临床症状明显好转;3)无效:患者经过治疗后,临床症状未见改善或加重;4)对照组合试验组的患者无论性别或肿瘤类型均采用随机选取分组。
由表1可知,本发明中药组合物对各类肿瘤的有效率达到94.67%,长期服用可抑制或预防细胞病变,增强人体免疫功能,延长患者生存时长,提高患者生命质量。
二、部分典型病例:
病例1:朱某,男,1968年生,河南信阳市人,经诊断为肺癌脑转移,服用本发明实施例1配方中药组合物治疗,每日两次用药,每次5克,转移灶逐渐缩小,病情稳定,现正在持续用药中。
病例2:李某,男,1958年生,河南新蔡人,经诊断为胃癌,服用本发明实施例3配方中药组合物治疗,坚持服用2年,经西医复查,生理数据基本正常,自身感觉良好,停药已三年,无复发。
病例3:田某,男,1943年生,河南栾川县人,经诊断为食道癌,经本发明实施例3配方治疗后,坚持服药,除硬食物外,可进软流汁食物,梗塞感消失,生存时限已延长8年,现仍健在。
以上所述仅为本发明的较佳实施例而已,并不用以限制本发明,凡在本发明的精神和原则之内,所做的任何修改、等同替换、改进等,均应包含在本发明保护的范围之内。
Claims (7)
1.一种用于治疗肿瘤的中药组合物,其特征在于:该中药组份以及各组份的重量份数为黄芪10~20份,红参5~10份,灵芝5~10份,千斤拔5~10份,羚羊角0.1~0.3份,蚂蚁3~9份,皂针5~10份,猫爪草10~15份,紫花地丁10~15份,蜣螂5~10份,鼠妇3~9份,麝香0.1~0.3份。
2.根据权利要求1所述的一种用于治疗肿瘤的中药组合物,其特征在于:该中药组份以及各组份的重量份数为黄芪15份,红参8份,灵芝8份,千斤拔8份,羚羊角0.2份,蚂蚁6份,皂针7份,猫爪草13份,紫花地丁13份,蜣螂7份,鼠妇6份,麝香0.2份。
3.根据权利要求1~2任一所述的用于治疗肿瘤的中药组合物,其特征在于:该中药组合物重量单位为克或千克为计量单位,依据所需数量而定。
4.根据权利要求3任一所述的用于治疗肿瘤的中药组合物,其特征在于:所述的中药组合物以原料的溶剂提取物为活性成分,加上药学上可接收的载体制成的制剂。
5.根据权利要求4任一所述的用于治疗肿瘤的中药组合物,其特征在于:所述的制剂为口服液、颗粒剂、胶囊剂或片剂。
6.根据权利要求5所述的一种用于治疗肿瘤的中药组合物,其特征在于:所述的中药组合物可用于治疗肺癌、肝癌、胃癌、食道癌、乳腺癌、肠癌、子宫癌中的任意一种。
7.如权利要求1所述的用于治疗肿瘤的中药组合物的制备方法,其特征在于:该方法包括以下步骤:
步骤1:取得黄芪、红参、灵芝、千斤拔、羚羊角、蚂蚁、皂针、猫爪草、紫花地丁、蜣螂、鼠妇、麝香原材料,分别进行炮制,制得原料药,备用;
步骤2:将步骤1制得原料药分别进行粉碎至80~120目,采用超声波设备对原料药粉末进行破壁,得到原料药的破壁粉末备用;
步骤3:将上述的破壁粉末加入原料药总重量4-8倍量水加热循环煎煮2~5次,每次煎煮时长为1~3h,过滤后将煎煮药液在恒温50-55℃条件下浓缩至含水量在50%~60%的膏状药剂,即为所述得中药组合物;
步骤4:将步骤3中所述的膏状药剂加入药物学可接受的载体制备制剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910993772.2A CN110604775A (zh) | 2019-10-18 | 2019-10-18 | 一种用于治疗肿瘤的中药组合物及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910993772.2A CN110604775A (zh) | 2019-10-18 | 2019-10-18 | 一种用于治疗肿瘤的中药组合物及制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110604775A true CN110604775A (zh) | 2019-12-24 |
Family
ID=68893081
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910993772.2A Pending CN110604775A (zh) | 2019-10-18 | 2019-10-18 | 一种用于治疗肿瘤的中药组合物及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110604775A (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101856477A (zh) * | 2009-04-07 | 2010-10-13 | 张毅 | 一种治疗癌症的中药及制备方法 |
CN104069294A (zh) * | 2014-03-28 | 2014-10-01 | 上海远东中医药研究所 | 一种抗癌中成药制剂及其提取配伍工艺 |
CN107243022A (zh) * | 2017-06-21 | 2017-10-13 | 薛寿文 | 治疗癌症的中药蜜丸及其制备方法 |
-
2019
- 2019-10-18 CN CN201910993772.2A patent/CN110604775A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101856477A (zh) * | 2009-04-07 | 2010-10-13 | 张毅 | 一种治疗癌症的中药及制备方法 |
CN104069294A (zh) * | 2014-03-28 | 2014-10-01 | 上海远东中医药研究所 | 一种抗癌中成药制剂及其提取配伍工艺 |
CN107243022A (zh) * | 2017-06-21 | 2017-10-13 | 薛寿文 | 治疗癌症的中药蜜丸及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104225441A (zh) | 一种治疗胃病的中药组合物及其颗粒剂和胶囊剂的制备方法 | |
CN106267120A (zh) | 一种治疗鼻炎的中药制剂及其制备方法 | |
CN105535575A (zh) | 减轻化疗副反应的药物 | |
CN110742990B (zh) | 一种治疗非酒精性单纯性脂肪肝的中药组合物及制剂和应用 | |
CN104721702A (zh) | 一种治疗结肠癌的中药 | |
CN105326993A (zh) | 一种治疗遗精、早泄的中药组合物 | |
CN104587206A (zh) | 治疗褥疮的药物及制备方法 | |
CN103920046A (zh) | 一种用于治疗膀胱炎的药物及制备方法 | |
CN103417911A (zh) | 化疗辅助用中药组合物 | |
CN104474202B (zh) | 一种治疗厌食的药物组合物 | |
CN110604775A (zh) | 一种用于治疗肿瘤的中药组合物及制备方法 | |
CN103550528B (zh) | 一种治疗胃阴不足型慢性胃炎的中药制剂及制备方法 | |
CN104840902A (zh) | 一种治疗卵巢肿瘤的中药制剂 | |
CN105434739A (zh) | 一种治疗霰粒肿的中药组合物及其制备方法 | |
CN104491060A (zh) | 预防脑胶质瘤复发的中药 | |
CN104383466A (zh) | 一种治疗肝肾阴虚型子宫颈癌的中药及制备方法 | |
CN103977276A (zh) | 治疗放射性膀胱炎的中药胶囊 | |
CN104337955A (zh) | 一种治疗肝癌的中药配方及其制备方法 | |
CN103285131B (zh) | 一种治疗乳腺炎的中药洗液 | |
CN114053358A (zh) | 一种抗肿瘤中药组合物、药物及其应用和制备方法 | |
CN106237156A (zh) | 一种治疗胃癌的中药组合物及其制备方法 | |
CN106361881A (zh) | 一种用于治疗阴囊湿疹的汤剂药物及其制备方法 | |
CN105617099A (zh) | 一种治疗肿瘤化疗引起的不良反应的药物及制备方法 | |
CN104587399A (zh) | 治疗卵巢囊肿的中药配方 | |
CN104383338A (zh) | 一种治疗慢性肾绞痛的中药制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20191224 |
|
RJ01 | Rejection of invention patent application after publication |